First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer Post author: Post published:April 26, 2024 Post category:uncategorized The real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer. You Might Also Like Amsterdam UMC project aims for first effective HIV vaccine with Gates funding January 16, 2024 The healing power of touch: Study finds moderate health benefits across ages April 9, 2024 UnitedHealth wins ruling over $2B in alleged Medicare Advantage overpayments March 4, 2025